These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 3879313)
1. The importance of early treatment of renal bone disease in children. Chesney RW; Dabbagh S; Uehling DT; DeLuca HF Kidney Int Suppl; 1985 Dec; 17():S75-8. PubMed ID: 3879313 [No Abstract] [Full Text] [Related]
2. Are new vitamin D analogues in renal bone disease superior to calcitriol? Salusky IB Pediatr Nephrol; 2005 Mar; 20(3):393-8. PubMed ID: 15690188 [TBL] [Abstract][Full Text] [Related]
3. Use of vitamin D analogs in renal osteodystrophy. Johnson WJ Semin Nephrol; 1986 Mar; 6(1):31-41. PubMed ID: 3037668 [No Abstract] [Full Text] [Related]
4. [Use of vitamin D 2 and its metabolites in chronic glomerulonephritis in children]. Naumova VI; Rusnak FI; Vereskova SA; Kutafina EK; Panchenko EL Pediatriia; 1989; (5):19-22. PubMed ID: 2671919 [TBL] [Abstract][Full Text] [Related]
5. Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol. Hodson EM; Evans RA; Dunstan CR; Hills E; Wong SY; Rosenberg AR; Roy LP Clin Nephrol; 1985 Oct; 24(4):192-200. PubMed ID: 3877585 [TBL] [Abstract][Full Text] [Related]
7. Ergocalciferol versus calcitriol for controlling chronic kidney disease mineral bone disorder in stage 3 to 5 CKD: A randomized controlled trial. Zhang D; Li H; Yin D; Wang L; Ma Y Eur J Pharmacol; 2016 Oct; 789():127-133. PubMed ID: 27401037 [TBL] [Abstract][Full Text] [Related]
8. [The effects of estrogen on renal osteodystrophy in the female patients undergoing maintenance hemodialysis]. Akino H; Saito A; Maeda S; Kitajima W; Okano M; Isomatsu Y; Muranaka K; Kanimoto Y; Shimizu Y; Kawada Y Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1129-36. PubMed ID: 3807045 [No Abstract] [Full Text] [Related]
9. [Hydroxylated metabolites of vitamin D. Therapeutic use of calcitriol and dihydrotachysterol]. Stĕpán J; Lachmanová J; Wilczek H; Straková M; Zichová M; Horn V; Tomásek R; Pacovský V Cas Lek Cesk; 1985 Dec; 124(50):1550-6. PubMed ID: 3841297 [No Abstract] [Full Text] [Related]
10. [Case of familial juvenile nephronophthiasis: intestinal calcium absorption and effects of vitamin D 2]. Kiyono Y; Iida H; Okada H; Shimotsuji T Nihon Shonika Gakkai Zasshi; 1972 Jan; 76(1):18-26. PubMed ID: 4537137 [No Abstract] [Full Text] [Related]
12. Calcitriol and calcium carbonate therapy in early chronic renal failure. Fournier A Nephrol Dial Transplant; 1995; 10(4):577. PubMed ID: 7624009 [No Abstract] [Full Text] [Related]
13. [Therapeutic use of vitamin D, its derivatives and their analogs]. Vagneur JP; Argemi B Diabete Metab; 1982 Mar; 8(1):65-7. PubMed ID: 6980150 [No Abstract] [Full Text] [Related]
14. Osteodystrophy of dialysed patients treated with vitamin D. Verberckmoes R; Bouillon R; Krempien B Proc Eur Dial Transplant Assoc; 1973; 10(0):217-26. PubMed ID: 4370246 [No Abstract] [Full Text] [Related]
15. Renal osteodystrophy in children with end-stage kidney failure. Chan JC Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255 [TBL] [Abstract][Full Text] [Related]
16. Calciferol induced hypercalcemia in renal osteodystrophy. Meme JS; Njai DN; Otieno LS; Kalya R East Afr Med J; 1980 Oct; 57(10):712-5. PubMed ID: 6971215 [No Abstract] [Full Text] [Related]
19. Effects of 1,25(OH)2D3 administration on bone in patients with renal failure. Malluche HH; Faugere MC Kidney Int Suppl; 1990 Sep; 29():S48-53. PubMed ID: 2214547 [No Abstract] [Full Text] [Related]
20. Calcitriol injection for the management of renal osteodystrophy. Peacock E ANNA J; 1992 Dec; 19(6):575-7. PubMed ID: 1292420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]